Observation of using low-dose Lishengsu for the Leukocyte reducing in Malignant Tumor Chemotherapy

Objective To appraise the curative effect of using low dose lishengsu for the leukocyte reducing in malignant tumor chemotherapy. Methods The rhG CSF(Lishegsu) at a dose of 75μg/body•day was given subcataneously for forty five patients with the leukocyte reducing in malignant tumor chemotherapy,and their average leukocyte count were(1.85±2.66)×10 9/L before receiving the treatment. Results The time of fory five patients s circum leukocyte count upawing to availability(18 cases)or producing effects,was...